上饶市45例新型冠状病毒肺炎患者的临床特征分析及其防治对策

Analysis on Clinical Characteristics of 45 Patients with COVID-19 in Shangrao and Their Prevention and Control Countermeasures

目的:分析上饶地区新型冠状病毒肺炎(COVID-19)确诊病例的临床特征及治疗效果。方法:收集医院2020年1月22日—3月2日间收治的COVID-19确诊患者45例临床资料;分析其临床表现和实验室、胸部CT检测结果及治疗策略。结果:45例COVID-19患者中,其中轻型和普通型43例、重型1例和危重型1例;临床症状以发热、咳嗽为主;血常规表现为白细胞总数下降或正常,淋巴细胞计数下降;生化指标以胆红素水平异常为主,表现为总胆红素、间接胆红素升高较明显;80%的病例胸部CT呈肺炎影像学特征;抗病毒治疗为主要方案,若疗效较差时,其与莫西沙星联用的疗效较佳。结论:上饶地区COVID-19病例以轻型和普通型为主,抗病毒治疗总体治疗效果较好。

Objective:To analyze the clinical characteristics and efficacy of patients with novel coronavirus pneumonia(COVID-19)in ShangRao.Methods:Clinical data of 45 confirmed COVID-19 patients admitted to the hospital from January 22 to March 2,2020 were collected.The clinical manifestations,laboratory,chest CT findings and treatment strategies were analyzed.Results:Of the 45 COVID-19 patients(43 were mild and normal,1 was severe,and 1 was critical).The clinical symptoms were fever and cough.The blood routine showed that the total number of white blood cells was decreased or normal,and the lymphocyte was decreased.The biochemical indexes were mainly bilirubin abnormality,which showed that the total bilirubin and indirect bilirubin increased significantly.Chest CT showed imaging features of pneumonia in 80%of cases.Antiviral treatment was the main regimen,antiviral therapy was the main regimen.If the efficacy was poor,the combination with moxifloxacin was more effective.Conclusions:The cases of COVID-19 in Shangrao area were mainly mild and common,and the overall therapeutic efficacies of antiviral medication were good.